Aurinia Pharmaceuticals Inc. — Director's Dealing 2021

Jun 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2021-06-14

Reporting Person: Jayne David R.W. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-14	Stock Option (right to buy)	$12.86	A	31347	Acquired	2031-06-14	Common Shares (31347.0)	Direct

Footnotes

F1: The option vests in twelve equal monthly installments commencing on July 14, 2021.